Resultados de búsqueda - Kensei Tobinai

Limitar resultados
  1. 1
    Clinical development of anti‐<scp>CD</scp>19 chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma

    Clinical development of anti‐<scp>CD</scp>19 chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma por Shinichi Makita, Kiyoshi Yoshimura, Kensei Tobinai

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies

    A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies por Olivier Hermine, Juan Carlos Ramos, Kensei Tobinai

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  3. 3
    A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies

    A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies por Kensei Tobinai, Christian Klein, Naoko Oya, Günter Fingerle‐Rowson

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  4. 4
    Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma

    Clinicopathologic, immunophenotypic, and immunogenotypic analyses of immunoblastic lymphadenopathy-like T-cell lymphoma por Kensei Tobinai, K Minato, T Ohtsu, K Mukai, Yoshikazu Kagami, M Miwa, S Watanabe, M Shimoyama

    Publicado 1988
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Phase I study of anti‐<scp>CD</scp>22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory <scp>B</scp>‐cell non‐<scp>H</scp>odgkin lymphoma

    Phase I study of anti‐<scp>CD</scp>22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory <scp>B</scp>‐cell non‐<scp>H</scp>odgkin lymphoma por Michinori Ogura, Kiyohiko Hatake, Kiyoshi Ando, Kensei Tobinai, Kota Tokushige, Chiho Ono, Taro Ishibashi, Erik Vandendries

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction.

    Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by u... por T. Kinoshita, M Shimoyama, Kensei Tobinai, Mizuko Ito, Shinichiro ITO, Shigemasa Ikeda, Keisuke Tajima, K Shimotohno, Takashi Sügimura

    Publicado 1989
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma

    Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma por Kensei Tobinai, Yukio Kobayashi, Masaru Narabayashi, Michinori Ogura, Yoshitoyo Kagami, Y Morishima, T. Ohtsu, Tomofumi Igarashi, Yosuke Sasaki, T. Kinoshita, Takashi Murate

    Publicado 1998
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Clinicopathological features of histological transformation from extranodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue to diffuse large B‐cell lymphoma: an analysis of 467 patients

    Clinicopathological features of histological transformation from extranodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue to diffuse large B‐cell lymphoma: an... por Akiko Miyagi Maeshima, Hirokazu Taniguchi, Kosuke Toyoda, Nobuhiko Yamauchi, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Dai Maruyama, Yukio Kobayashi, Kensei Tobinai

    Publicado 2016
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Primary Bone Lymphoma: A New and Detailed Characterization of 28 Patients in a Single-Institution Study

    Primary Bone Lymphoma: A New and Detailed Characterization of 28 Patients in a Single-Institution Study por Dai Maruyama, Takashi Watanabe, Yasuo Beppu, Yukio Kobayashi, Sung‐Won Kim, Kazuki Tanimoto, Atsushi Makimoto, Yoshikazu Kagami, Takashi Terauchi, Yoshihiro Matsuno, Kensei Tobinai

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma

    Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma por Hiroyuki Saito, Dai Maruyama, Akiko Miyagi Maeshima, Shinichi Makita, Hideaki Kitahara, K Miyamoto, Suguru Fukuhara, Wataru Munakata, T. Suzuki, Yukio Kobayashi, Hirokazu Taniguchi, Kensei Tobinai

    Publicado 2015
    Enlace del recurso Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  11. 11
    The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project

    The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project por Junji Suzumiya, K Ohshima, Kazuo Tamura, Kennosuke Karube, Naokuni Uike, Kensei Tobinai, Randy D. Gascoyne, Julie M. Vose, Jamés O. Armitage, Dennis D. Weisenburger

    Publicado 2009
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia.

    Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia. por H. Hoshino, Hiroyasu Esumi, Masanao Miwa, M Shimoyama, K Minato, Kensei Tobinai, Masaki Hirose, Shaw Watanabe, N Inada, K Kinoshita, S Kamihira, Michito Ichimaru, Takashi Sügimura

    Publicado 1983
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    Preengraftment Serum C-Reactive Protein (CRP) Value May Predict Acute Graft-versus-Host Disease and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation

    Preengraftment Serum C-Reactive Protein (CRP) Value May Predict Acute Graft-versus-Host Disease and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation por Shigeo Fuji, Sung Won Kim, Takahiro Fukuda, Shin‐ichiro Mori, Satoshi Yamasaki, Yuriko Morita‐Hoshi, Fusako Ohara-Waki, Yuji Heike, Kensei Tobinai, Ryuji Tanosaki, Yoichi Takaue

    Publicado 2008
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma

    Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma por Kazuki Tanimoto, Akihiro Kaneko, Shigenobu Suzuki, Naohiro Sekiguchi, Dai Maruyama, S.W. Kim, Takashi Watanabe, Yukio Kobayashi, Yoshikazu Kagami, A.M. Maeshima, Yoshihiro Matsuno, Kensei Tobinai

    Publicado 2005
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Phase I study of tirabrutinib (<scp>ONO</scp>‐4059/<scp>GS</scp>‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan

    Phase I study of tirabrutinib (<scp>ONO</scp>‐4059/<scp>GS</scp>‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan por Wataru Munakata, Kiyoshi Ando, Kiyohiko Hatake, Noriko Fukuhara, Tomohiro Kinoshita, Suguru Fukuhara, Yukari Shirasugi, Masahiro Yokoyama, Satoshi Ichikawa, Ken Ohmachi, Naokazu Gion, Arata Aoi, Kensei Tobinai

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  16. 16
    Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma

    Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma por Takashi Watanabe, Harumi Kato, Yukio Kobayashi, Satoshi Yamasaki, Yuriko Morita‐Hoshi, Hiroki Yokoyama, Yasuo Morishima, Justin L. Ricker, Tetsuya Otsuki, Akiko Miyagi‐Maesima, Yoshihiro Matsuno, Kensei Tobinai

    Publicado 2009
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  17. 17
    Phase I / II study of brentuximab vedotin in <scp>J</scp>apanese patients with relapsed or refractory <scp>CD</scp>30‐positive <scp>H</scp>odgkin's lymphoma or systemic anaplastic large‐cell lymphoma

    Phase I / II study of brentuximab vedotin in <scp>J</scp>apanese patients with relapsed or refractory <scp>CD</scp>30‐positive <scp>H</scp>odgkin's lymphoma or systemic anaplastic... por Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, Kenichi Ishizawa, Naokuni Uike, Toshiki Uchida, Tatsuya Suzuki, Tomohiro Aoki, Takashi Watanabe, Dai Maruyama, Masahiro Yokoyama, Takatoshi Takubo, Hideaki Kagehara, Takafumi Matsushima

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  18. 18
    Multicenter phase <scp>II</scp> study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma

    Multicenter phase <scp>II</scp> study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma por Dai Maruyama, Kiyohiko Hatake, Tomohiro Kinoshita, Noriko Fukuhara, Ilseung Choi, Masafumi Taniwaki, Kiyoshi Ando, Yasuhito Terui, Yusuke Higuchi, Yasushi Onishi, Yasunobu Abe, Tsutomu Kobayashi, Yukari Shirasugi, Kensei Tobinai

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  19. 19
    Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211

    Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211 por Motoko Yamaguchi, Kensei Tobinai, Masahiko Oguchi, Naoki Ishizuka, Yukio Kobayashi, Yasushi Isobe, Kenichi Ishizawa, Nobuo Maseki, Kuniaki Itoh, Noriko Usui, Izumi Wasada, Tomohiro Kinoshita, Tomomitsu Hotta, Kunihiro Tsukasaki, Kazuo Oshimi

    Publicado 2012
    Enlace del recurso Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  20. 20
    Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and <scp>II</scp> studies

    Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and <scp>II</scp> studies por Takashi Ishida, Atae Utsunomiya, Tatsuro Jo, Kazuhito Yamamoto, Koji Kato, Shinichiro Yoshida, Shigeki Takemoto, Hitoshi Suzushima, Yukio Kobayashi, Yoshitaka Imaizumi, Kenichi Yoshimura, Kouichi Kawamura, Takeshi Takahashi, Kensei Tobinai, Ryuzo Ueda

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: